Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Benlonac-SR Tablet

Prescription Icon
Prescription Required

Marketer

Ben Hadded Pharma Pvt Ltd

Salt Composition

Aceclofenac (200mg)

Overview Benlonac-SR Tablet

RheumaSolve Extended Release tablets provide pain and inflammation relief. Indicated for conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, dosage and duration should strictly follow your physician's instructions. Administer with food or milk to minimize gastrointestinal discomfort. Consistent, timely ingestion optimizes therapeutic efficacy. Continue treatment as prescribed until your doctor advises cessation. Common side effects include nausea, vomiting, indigestion, and stomach pain; dizziness, drowsiness, or blurred vision may also occur. Prolonged use necessitates regular monitoring of kidney and liver function, along with blood component levels. Extended therapy carries a risk of serious complications, including peptic ulcers and renal impairment. RheumaSolve Extended Release tablets are contraindicated during pregnancy and lactation.

Primary Ingredients of Benlonac-SR Tablet

The information is unavailable.

Uses of Benlonac-SR Tablet

Analgesia

Major Benefits of Benlonac-SR Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Benlonac-SR Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Benlonac-SR Tablet:

  • Vomiting
  • Stomach pain/epigastric pain
  • Nausea
  • Indigestion
  • Diarrhea
  • Heartburn
  • Loss of appetite

How to use Benlonac-SR Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Benlonac-SR Tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with food.

How Benlonac-SR Tablet works:

Benlonac-SR tablets are non-steroidal anti-inflammatory drugs (NSAIDs) that inhibit the production of specific inflammatory mediators, thus alleviating pain and reducing associated inflammation, such as redness and swelling.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Benlonac-SR Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Benlonac-SR Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Benlonac-SR Tablet use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving may be impaired by Benlonac-SR Tablets, which can cause drowsiness, dizziness, and visual disturbances. Refrain from operating a vehicle if you experience these side effects.

KidneyKidneyCAUTION

Exercise caution when administering Benlonac-SR Tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Benlonac-SR Tablets are contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Patients with hepatic impairment should use Benlonac-SR Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Benlonac-SR Tablets are contraindicated in patients with severe liver dysfunction. Routine monitoring of liver enzyme levels is advised during treatment.

What if you forget to take Benlonac-SR Tablet :

Should you forget a Benlonac-SR Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Benlonac-SR Tablet

LabelValue
Type of Compound Compound derived from dichlorobenzene
Potential for Dependence None.
Type of Treatment Pain relievers
Mechanism of Action Nonsteroidal anti-inflammatory drugs (NSAIDs) that non-selectively inhibit cyclooxygenase-1 and -2 (acetic acid derivatives).

FAQs on Benlonac-SR Tablet

Benlonac-SR Tablets effectively alleviate pain and inflammation. This medication offers pain relief for conditions including sprains, strains, and other injuries. It also provides benefit in managing various arthritic conditions, gout, and post-surgical pain and inflammation.
Using Benlonac-SR Tablets as prescribed by your physician ensures safe usage. Adhere strictly to the recommended dosage and frequency; do not omit any doses. Closely follow your doctor's guidelines and report any concerning side effects.
Benlonac-SR Tablets do not produce euphoria and pose no risk of misuse or addiction, either physically or psychologically. Nevertheless, seek medical advice if you experience any adverse effects.
Extended use and substantial dosages of Benlonac-SR Tablet can lead to renal complications, including proteinuria, hematuria, and dysuria. Individuals with a history of, or current, congestive heart failure, compromised renal function, or hypertension are at heightened risk of developing these renal issues. This risk is further amplified in patients concurrently using diuretics or other nephrotoxic medications. Furthermore, patients aged 65 and older, or those experiencing dehydration, may also experience adverse renal effects from Benlonac-SR Tablet. Consequently, regular assessment of kidney function is advised for these patient populations.
Remembered a missed Benlonac-SR Tablet dose? Take it immediately. But, if your next dose is nearly due, omit the missed one and continue with your regular schedule. Never double a dose to compensate; doing so might heighten the risk of adverse reactions.
Taking Benlonac-SR Tablets may lead to somnolence, vertigo, lassitude, and blurred vision. These side effects are infrequent and not universally experienced. Refrain from driving or operating complex equipment if such symptoms occur.
Using Benlonac-SR Tablets elevates the risk of heart attack or stroke, particularly with higher doses or prolonged use. The medication can also induce stomach and intestinal ulcers, bleeding, or perforations, potentially fatal and occurring without prior warning at any point during therapy. Immediate medical attention is crucial should such complications arise.
Avoid Benlonac-SR Tablet during the final trimester of pregnancy due to potential harm to the fetus. This medication may also precipitate premature birth. It's advisable to abstain from Benlonac-SR Tablet use throughout the first half of pregnancy as well. Prescribing may occur in pregnant individuals only when potential benefits surpass identified risks. Seek medical counsel if you have any uncertainties.
Following your doctor's prescribed dosage and treatment length is crucial for optimal Benlonac-SR Tablet effectiveness. Continue taking the medication as directed, even with symptom improvement. Premature discontinuation of Benlonac-SR Tablet may lead to symptom recurrence or exacerbation.
Benlonac-SR Tablet
32
MRP 39
17% off